The complexity, diversity, and heterogeneity of tumors seriously undermine the therapeutic
potential of treatment. Therefore, the current trend in clinical research has gradually shifted …

Advances in the field of nanotechnology together with an increase understanding of tumor
immunology have paved the way for the development of more personalized cancer immuno …

The highly immunosuppressive tumor microenvironment (TME) in solid tumors often
dampens the efficacy of immunotherapy. In this study, bacterial outer membrane vesicles …

Cancer immunotherapies that harness the body's immune system to combat tumors have
received extensive attention and become mainstream strategies for treating cancer. Despite …

Immunotherapy has revolutionized oncology remarkably and gained great improvements in
cancer therapy. However, tumor immunotherapy still encounters serious challenges …

Cytosolic protein delivery is a prerequisite for protein‐based biotechnologies and
therapeutics on intracellular targets. Polymers that can complex with proteins to form nano …

Personalized cancer vaccines (PCVs) are reinvigorating vaccine strategies in cancer
immunotherapy. In contrast to adoptive T-cell therapy and checkpoint blockade, the PCV …

Cancer nanovaccines as one of immunotherapeutic approaches are able to attack tumors by
stimulating tumor-specific immunological responses. However, there still exist multiple …

Immunotherapy will significantly impact the standard of care in cancer treatment. Recent
advances in nanotechnology can improve the efficacy of cancer immunotherapy. However …

Advances in phototheranostics revolutionized glioma intraoperative fluorescence imaging
and phototherapy. However, the lack of desired active targeting agents for crossing the …